{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["6-hydroxydopamine", "apoptosis", "biological products", "cell culture techniques", "mitochondrial membrane potential", "neurodegenerative diseases", "neurodegenerative disorders", "neuroprotective effect", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35328335", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "08"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "08"}], "Language": ["eng"], "ELocationID": ["2914", "10.3390/ijms23062914"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "6", "PubDate": {"Year": "2022", "Month": "Mar", "Day": "08"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Neuroprotective Effect of Luteolin-7-O-Glucoside against 6-OHDA-Induced Damage in Undifferentiated and RA-Differentiated SH-SY5Y Cells.", "Abstract": {"AbstractText": ["Luteolin is one of the most common flavonoids present in edible plants and its potential benefits to the central nervous system include decrease of microglia activation, neuronal damage and high antioxidant properties. The aim of this research was to evaluate the neuroprotective, antioxidant and anti-inflammatory activities of luteolin-7-O-glucoside (Lut7). Undifferentiated and retinoic acid (RA)-differentiated SH-SY5Y cells were pretreated with Lut7 and incubated with 6-hydroxydopamine (6-OHDA). Cytotoxic and neuroprotective effects were determined by MTT assay. Antioxidant capacity was determined by DPPH, FRAP, and ORAC assays. ROS production, mitochondrial membrane potential (\u0394\u03a8m), Caspase-3 activity, acetylcholinesterase inhibition (AChEI) and nuclear damage were also determined in SH-SY5Y cells. TNF-\u03b1, IL-6 and IL-10 release were evaluated in LPS-induced RAW264.7 cells by ELISA. In undifferentiated SH-SY5Y cells, Lut7 increased cell viability after 24 h, while in RA-differentiated SH-SY5Y cells, Lut7 increased cell viability after 24 and 48 h. Lut7 showed a high antioxidant activity when compared with synthetic antioxidants. In undifferentiated cells, Lut7 prevented mitochondrial membrane depolarization induced by 6-OHDA treatment, decreased Caspase-3 and AChE activity, and inhibited nuclear condensation and fragmentation. In LPS-stimulated RAW264.7 cells, Lut7 treatment reduced TNF-\u03b1 levels and increased IL-10 levels after 3 and 24 h, respectively. In summary, the results suggest that Lut7 has neuroprotective effects, thus, further studies should be considered to validate its pharmacological potential in more complex models, aiming the treatment of neurodegenerative diseases."]}, "AuthorList": [{"Identifier": ["0000-0002-0362-3129"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cell Culture Laboratory, Graduate Program in Biotechnology, University of Vale do Taquari (Univates), Lajeado 95914-014, RS, Brazil."}], "LastName": "Rehfeldt", "ForeName": "Stephanie Cristine Hepp", "Initials": "SCH"}, {"Identifier": ["0000-0003-1224-1699"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Marine and Environmental Sciences Centre (MARE), Polytechnic of Leiria, 2520-630 Peniche, Portugal."}], "LastName": "Silva", "ForeName": "Joana", "Initials": "J"}, {"Identifier": ["0000-0003-1581-2127"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Marine and Environmental Sciences Centre (MARE), Polytechnic of Leiria, 2520-630 Peniche, Portugal."}], "LastName": "Alves", "ForeName": "Celso", "Initials": "C"}, {"Identifier": ["0000-0002-3290-3111"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Marine and Environmental Sciences Centre (MARE), Polytechnic of Leiria, 2520-630 Peniche, Portugal."}], "LastName": "Pinteus", "ForeName": "Susete", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "MARE-Marine and Environmental Sciences Centre, ESTM, Polytechnic of Leiria, 2520-614 Peniche, Portugal."}], "LastName": "Pedrosa", "ForeName": "Rui", "Initials": "R"}, {"Identifier": ["0000-0001-6952-1486"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Eberhard Karls Universit\u00e4t T\u00fcbingen, D 72076 Tubingen, Germany."}, {"Identifier": [], "Affiliation": "T\u00fcbingen Center for Academic Drug Discovery (T\u00fcCAD2), D 72076 Tubingen, Germany."}], "LastName": "Laufer", "ForeName": "Stefan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cell Culture Laboratory, Graduate Program in Biotechnology, University of Vale do Taquari (Univates), Lajeado 95914-014, RS, Brazil."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Eberhard Karls Universit\u00e4t T\u00fcbingen, D 72076 Tubingen, Germany."}], "LastName": "Goettert", "ForeName": "M\u00e1rcia In\u00eas", "Initials": "MI"}], "GrantList": [{"GrantID": "001", "Agency": "Coordena\u00e7\u00e3o de Aperfeicoamento de Pessoal de N\u00edvel Superior", "Country": ""}, {"GrantID": "420381/2018-0", "Agency": "Conselho Nacional de Pesquisa (CNPq)", "Country": ""}, {"GrantID": "UID/04292/2020", "Agency": "Portuguese Foundation for Science and Technology(FCT)", "Country": ""}, {"GrantID": "UIDP/04046/2020 and UIDB/04046/2020", "Agency": "BioISI-BioSystems and Integrative Sciences Institute", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "130068-27-8", "NameOfSubstance": "Interleukin-10"}, {"RegistryNumber": "5688UTC01R", "NameOfSubstance": "Tretinoin"}, {"RegistryNumber": "8HW4YBZ748", "NameOfSubstance": "Oxidopamine"}, {"RegistryNumber": "98J6XDS46I", "NameOfSubstance": "luteolin-7-glucoside"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspase 3"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Flavones"}, {"QualifierName": [], "DescriptorName": "Glucosides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-10"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": [], "DescriptorName": "Membrane Potential, Mitochondrial"}, {"QualifierName": ["metabolism"], "DescriptorName": "Neuroblastoma"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["toxicity"], "DescriptorName": "Oxidopamine"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tretinoin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gammon K. Neurodegenerative disease: Brain windfall. Nature. 2014;515:299\u2013300. doi: 10.1038/nj7526-299a.", "ArticleIdList": ["10.1038/nj7526-299a", "25396246"]}, {"Citation": "Rezak M., de Carvalho M. Disease modification in neurodegenerative diseases: Not quite there yet. Neurology. 2020;94:12\u201313. doi: 10.1212/WNL.0000000000008690.", "ArticleIdList": ["10.1212/WNL.0000000000008690", "31792097"]}, {"Citation": "Bakhtiari M., Panahi Y., Ameli J., Darvishi B. Protective effects of flavonoids against Alzheimer\u2019s disease-related neural dysfunctions. Biomed. Pharmacother. 2017;93:218\u2013229. doi: 10.1016/j.biopha.2017.06.010.", "ArticleIdList": ["10.1016/j.biopha.2017.06.010", "28641164"]}, {"Citation": "Heim K.E., Tagliaferro A.R., Bobilya D.J. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 2002;13:572\u2013584. doi: 10.1016/S0955-2863(02)00208-5.", "ArticleIdList": ["10.1016/S0955-2863(02)00208-5", "12550068"]}, {"Citation": "Rasool M., Malik A., Qureshi M.S., Manan A., Pushparaj P.N., Asif M., Qazi M.H., Qazi A.M., Kamal M.A., Gan S.H., et al. Recent updates in the treatment of neurodegenerative disorders using natural compounds. Evid. Based Complement. Alternat. Med. 2014;2014:979730. doi: 10.1155/2014/979730.", "ArticleIdList": ["10.1155/2014/979730", "PMC4017872", "24864161"]}, {"Citation": "Goettert M., Schattel V., Koch P., Merfort I., Laufer S. Biological evaluation and structural determinants of p38\u03b1 mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids. Chembiochem. 2010;11:2579\u20132588. doi: 10.1002/cbic.201000487.", "ArticleIdList": ["10.1002/cbic.201000487", "21108268"]}, {"Citation": "Haeusgen W., Boehm R., Zhao Y., Herdegen T., Waetzig V. Specific activities of individual c-Jun N-terminal kinases in the brain. Neuroscience. 2009;161:951\u2013959. doi: 10.1016/j.neuroscience.2009.04.014.", "ArticleIdList": ["10.1016/j.neuroscience.2009.04.014", "19364525"]}, {"Citation": "Gourmaud S., Paquet C., Dumurgier J., Pace C., Bouras C., Gray F., Laplanche J.-L., Meurs E.F., Mouton-Liger F., Hugon J. Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: Links to cognitive decline. J. Psychiatry Neurosci. 2015;40:151\u2013161. doi: 10.1503/jpn.140062.", "ArticleIdList": ["10.1503/jpn.140062", "PMC4409432", "25455349"]}, {"Citation": "Takahashi R.H., Nagao T., Gouras G.K. Plaque formation and the intraneuronal accumulation of \u03b2-amyloid in Alzheimer\u2019s disease. Pathol. Int. 2017;67:185\u2013193. doi: 10.1111/pin.12520.", "ArticleIdList": ["10.1111/pin.12520", "28261941"]}, {"Citation": "Gourmaud S., Thomas P., Thomasseau S., Tible M., Abadie C., Paquet C., Hugon J. Brimapitide reduced neuronal stress markers and cognitive deficits in 5XFAD transgenic mice. J. Alzheimers Dis. 2018;63:665\u2013674. doi: 10.3233/JAD-171099.", "ArticleIdList": ["10.3233/JAD-171099", "29660941"]}, {"Citation": "Rehfeldt S.C.H., Laufer S., Goettert M.I. A Highly Selective In Vitro JNK3 Inhibitor, FMU200, Restores Mitochondrial Membrane Potential and Reduces Oxidative Stress and Apoptosis in SH-SY5Y Cells. Int. J. Mol. Sci. 2021;22:3701. doi: 10.3390/ijms22073701.", "ArticleIdList": ["10.3390/ijms22073701", "PMC8037381", "33918172"]}, {"Citation": "Dey A., Bhattacharya R., Mukherjee A., Pandey D.K. Natural products against Alzheimer\u2019s disease: Pharmaco-therapeutics and biotechnological interventions. Biotechnol. Adv. 2017;35:178\u2013216. doi: 10.1016/j.biotechadv.2016.12.005.", "ArticleIdList": ["10.1016/j.biotechadv.2016.12.005", "28043897"]}, {"Citation": "Uddin M.S., Kabir M.T., Niaz K., Jeandet P., Cl\u00e9ment C., Mathew B., Rauf A., Rengasamy K.R.R., Sobarzo-S\u00e1nchez E., Ashraf G.M., et al. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer\u2019s Disease. Molecules. 2020;25:1267. doi: 10.3390/molecules25061267.", "ArticleIdList": ["10.3390/molecules25061267", "PMC7143946", "32168835"]}, {"Citation": "Majolo F., Martins A., Rehfeldt S., Henriques J.A.P., Contini V., Goettert M.I. Bioactive Natural Products. Volume 69. Elsevier; Amsterdam, The Netherlands: 2021. Approaches for the treatment of neurodegenerative diseases related to natural products; pp. 1\u201363. Studies in Natural Products Chemistry."}, {"Citation": "Silva J., Alves C., Martins A., Susano P., Sim\u00f5es M., Guedes M., Rehfeldt S., Pinteus S., Gaspar H., Rodrigues A., et al. Loliolide, a New Therapeutic Option for Neurological Diseases? In Vitro Neuroprotective and Anti-Inflammatory Activities of a Monoterpenoid Lactone Isolated from Codium tomentosum. Int. J. Mol. Sci. 2021;22:1888. doi: 10.3390/ijms22041888.", "ArticleIdList": ["10.3390/ijms22041888", "PMC7918146", "33672866"]}, {"Citation": "Silva J., Alves C., Pinteus S., Susano P., Sim\u00f5es M., Guedes M., Martins A., Rehfeldt S., Gaspar H., Goettert M., et al. Disclosing the potential of eleganolone for Parkinson\u2019s disease therapeutics: Neuroprotective and anti-inflammatory activities. Pharmacol. Res. 2021;168:105589. doi: 10.1016/j.phrs.2021.105589.", "ArticleIdList": ["10.1016/j.phrs.2021.105589", "33812007"]}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55\u201363. doi: 10.1016/0022-1759(83)90303-4.", "ArticleIdList": ["10.1016/0022-1759(83)90303-4", "6606682"]}, {"Citation": "Silva J., Alves C., Pinteus S., Mendes S., Pedrosa R. Neuroprotective effects of seaweeds against 6-hydroxidopamine-induced cell death on an in vitro human neuroblastoma model. BMC Complement. Altern. Med. 2018;18:58. doi: 10.1186/s12906-018-2103-2.", "ArticleIdList": ["10.1186/s12906-018-2103-2", "PMC5813419", "29444677"]}, {"Citation": "Pinteus S., Silva J., Alves C., Horta A., Fino N., Rodrigues A.I., Mendes S., Pedrosa R. Cytoprotective effect of seaweeds with high antioxidant activity from the Peniche coast (Portugal) Food Chem. 2017;218:591\u2013599. doi: 10.1016/j.foodchem.2016.09.067.", "ArticleIdList": ["10.1016/j.foodchem.2016.09.067", "27719954"]}, {"Citation": "D\u00e1valos A., G\u00f3mez-Cordov\u00e9s C., Bartolom\u00e9 B. Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay. J. Agric. Food Chem. 2004;52:48\u201354. doi: 10.1021/jf0305231.", "ArticleIdList": ["10.1021/jf0305231", "14709012"]}, {"Citation": "Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: The FRAP assay. Anal. Biochem. 1996;239:70\u201376. doi: 10.1006/abio.1996.0292.", "ArticleIdList": ["10.1006/abio.1996.0292", "8660627"]}, {"Citation": "Ouazia D., Levros L.C., Rassart \u00c9., Desrosiers R.R. The protein l-isoaspartyl (d-aspartyl) methyltransferase protects against dopamine-induced apoptosis in neuroblastoma SH-SY5Y cells. Neuroscience. 2015;295:139\u2013150. doi: 10.1016/j.neuroscience.2015.03.026.", "ArticleIdList": ["10.1016/j.neuroscience.2015.03.026", "25800307"]}, {"Citation": "Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88\u201395. doi: 10.1016/0006-2952(61)90145-9.", "ArticleIdList": ["10.1016/0006-2952(61)90145-9", "13726518"]}, {"Citation": "Santillo M.F., Liu Y. A fluorescence assay for measuring acetylcholinesterase activity in rat blood and a human neuroblastoma cell line (SH-SY5Y) J. Pharmacol. Toxicol. Methods. 2015;76:15\u201322. doi: 10.1016/j.vascn.2015.07.002.", "ArticleIdList": ["10.1016/j.vascn.2015.07.002", "26165232"]}, {"Citation": "Mansuri M.L., Parihar P., Solanki I., Parihar M.S. Flavonoids in modulation of cell survival signalling pathways. Genes Nutr. 2014;9:400. doi: 10.1007/s12263-014-0400-z.", "ArticleIdList": ["10.1007/s12263-014-0400-z", "PMC4026439", "24682883"]}, {"Citation": "Rahal A., Kumar A., Singh V., Yadav B., Tiwari R., Chakraborty S., Dhama K. Oxidative stress, prooxidants, and antioxidants: The interplay. Biomed Res. Int. 2014;2014:761264. doi: 10.1155/2014/761264.", "ArticleIdList": ["10.1155/2014/761264", "PMC3920909", "24587990"]}, {"Citation": "Nabavi S.F., Braidy N., Gortzi O., Sobarzo-Sanchez E., Daglia M., Skalicka-Wo\u017aniak K., Nabavi S.M. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review. Brain Res. Bull. 2015;119:1\u201311. doi: 10.1016/j.brainresbull.2015.09.002.", "ArticleIdList": ["10.1016/j.brainresbull.2015.09.002", "26361743"]}, {"Citation": "Kim S., Chin Y., Cho J. Protection of Cultured Cortical Neurons by Luteolin against Oxidative Damage through Inhibition of Apoptosis and Induction of Heme. Biol. Pharm. Bull. 2017;40:256\u2013265. doi: 10.1248/bpb.b16-00579.", "ArticleIdList": ["10.1248/bpb.b16-00579", "28250268"]}, {"Citation": "Luchtman D.W., Song C. Why SH-SY5Y cells should be differentiated. Neurotoxicology. 2010;31:164\u2013165. doi: 10.1016/j.neuro.2009.10.015. author reply 165.", "ArticleIdList": ["10.1016/j.neuro.2009.10.015", "19895843"]}, {"Citation": "Korecka J.A., van Kesteren R.E., Blaas E., Spitzer S.O., Kamstra J.H., Smit A.B., Swaab D.F., Verhaagen J., Bossers K. Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS ONE. 2013;8:e63862. doi: 10.1371/journal.pone.0063862.", "ArticleIdList": ["10.1371/journal.pone.0063862", "PMC3665836", "23724009"]}, {"Citation": "Krishna A., Biryukov M., Trefois C., Antony P.M.A., Hussong R., Lin J., Hein\u00e4niemi M., Glusman G., K\u00f6glsberger S., Boyd O., et al. Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson\u2019s disease. BMC Genom. 2014;15:1154. doi: 10.1186/1471-2164-15-1154.", "ArticleIdList": ["10.1186/1471-2164-15-1154", "PMC4367834", "25528190"]}, {"Citation": "de Medeiros L.M., De Bastiani M.A., Rico E.P., Schonhofen P., Pfaffenseller B., Wollenhaupt-Aguiar B., Grun L., Barb\u00e9-Tuana F., Zimmer E.R., Castro M.A.A., et al. Cholinergic Differentiation of Human Neuroblastoma SH-SY5Y Cell Line and Its Potential Use as an In vitro Model for Alzheimer\u2019s Disease Studies. Mol. Neurobiol. 2019;56:7355\u20137367. doi: 10.1007/s12035-019-1605-3.", "ArticleIdList": ["10.1007/s12035-019-1605-3", "31037648"]}, {"Citation": "Iakovleva I., Begum A., Pokrzywa M., Walfridsson M., Sauer-Eriksson A.E., Olofsson A. The flavonoid luteolin, but not luteolin-7-O-glucoside, prevents a transthyretin mediated toxic response. PLoS ONE. 2015;10:e0128222. doi: 10.1371/journal.pone.0128222.", "ArticleIdList": ["10.1371/journal.pone.0128222", "PMC4447256", "26020516"]}, {"Citation": "Cheung Y.-T., Lau W.K.-W., Yu M.-S., Lai C.S.-W., Yeung S.-C., So K.-F., Chang R.C.-C. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology. 2009;30:127\u2013135. doi: 10.1016/j.neuro.2008.11.001.", "ArticleIdList": ["10.1016/j.neuro.2008.11.001", "19056420"]}, {"Citation": "Schneider L., Giordano S., Zelickson B.R., S Johnson M., A Benavides G., Ouyang X., Fineberg N., Darley-Usmar V.M., Zhang J. Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress. Free Radic. Biol. Med. 2011;51:2007\u20132017. doi: 10.1016/j.freeradbiomed.2011.08.030.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.08.030", "PMC3208787", "21945098"]}, {"Citation": "de Bittencourt Pasquali M.A., de Ramos V.M., Albanus R.D.O., Kunzler A., de Souza L.H.T., Dalmolin R.J.S., Gelain D.P., Ribeiro L., Carro L., Moreira J.C.F. Gene Expression Profile of NF-\u03baB, Nrf2, Glycolytic, and p53 Pathways During the SH-SY5Y Neuronal Differentiation Mediated by Retinoic Acid. Mol. Neurobiol. 2016;53:423\u2013435. doi: 10.1007/s12035-014-8998-9.", "ArticleIdList": ["10.1007/s12035-014-8998-9", "25465239"]}, {"Citation": "Kunzler A., Zeid\u00e1n-Chuli\u00e1 F., Gasparotto J., Girardi C.S., Klafke K., Petiz L.L., Bortolin R.C., Rostirolla D.C., Zanotto-Filho A., de Bittencourt Pasquali M.A., et al. Changes in Cell Cycle and Up-Regulation of Neuronal Markers During SH-SY5Y Neurodifferentiation by Retinoic Acid are Mediated by Reactive Species Production and Oxidative Stress. Mol. Neurobiol. 2017;54:6903\u20136916. doi: 10.1007/s12035-016-0189-4.", "ArticleIdList": ["10.1007/s12035-016-0189-4", "27771902"]}, {"Citation": "Forster J.I., K\u00f6glsberger S., Trefois C., Boyd O., Baumuratov A.S., Buck L., Balling R., Antony P.M.A. Characterization of Differentiated SH-SY5Y as Neuronal Screening Model Reveals Increased Oxidative Vulnerability. J. Biomol. Screen. 2016;21:496\u2013509. doi: 10.1177/1087057115625190.", "ArticleIdList": ["10.1177/1087057115625190", "PMC4904349", "26738520"]}, {"Citation": "Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem. Sci. 2010;35:505\u2013513. doi: 10.1016/j.tibs.2010.04.002.", "ArticleIdList": ["10.1016/j.tibs.2010.04.002", "PMC2933303", "20430626"]}, {"Citation": "Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009;417:1\u201313. doi: 10.1042/BJ20081386.", "ArticleIdList": ["10.1042/BJ20081386", "PMC2605959", "19061483"]}, {"Citation": "Glinka Y., Gassen M., Youdim M.B. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural. Transm. Suppl. 1997;50:55\u201366. doi: 10.1007/978-3-7091-6842-4_7.", "ArticleIdList": ["10.1007/978-3-7091-6842-4_7", "9120425"]}, {"Citation": "Glinka Y., Tipton K.F., Youdim M.B. Nature of inhibition of mitochondrial respiratory complex I by 6-Hydroxydopamine. J. Neurochem. 1996;66:2004\u20132010. doi: 10.1046/j.1471-4159.1996.66052004.x.", "ArticleIdList": ["10.1046/j.1471-4159.1996.66052004.x", "8780029"]}, {"Citation": "Glinka Y., Tipton K.F., Youdim M.B. Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine. Eur. J. Pharmacol. 1998;351:121\u2013129. doi: 10.1016/S0014-2999(98)00279-9.", "ArticleIdList": ["10.1016/S0014-2999(98)00279-9", "9698213"]}, {"Citation": "Glinka Y.Y., Youdim M.B. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol. 1995;292:329\u2013332. doi: 10.1016/0926-6917(95)90040-3.", "ArticleIdList": ["10.1016/0926-6917(95)90040-3", "7796873"]}, {"Citation": "Cui X.-X., Yang X., Wang H.-J., Rong X.-Y., Jing S., Xie Y.-H., Huang D.-F., Zhao C. Luteolin-7-O-Glucoside Present in Lettuce Extracts Inhibits Hepatitis B Surface Antigen Production and Viral Replication by Human Hepatoma Cells in Vitro. Front. Microbiol. 2017;8:2425. doi: 10.3389/fmicb.2017.02425.", "ArticleIdList": ["10.3389/fmicb.2017.02425", "PMC5723679", "29270164"]}, {"Citation": "Palombo R., Savini I., Avigliano L., Madonna S., Cavani A., Albanesi C., Mauriello A., Melino G., Terrinoni A. Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model. Cell Death Dis. 2016;7:e2344. doi: 10.1038/cddis.2016.201.", "ArticleIdList": ["10.1038/cddis.2016.201", "PMC5108310", "27537526"]}, {"Citation": "De Stefano A., Caporali S., Di Daniele N., Rovella V., Cardillo C., Schinzari F., Minieri M., Pieri M., Candi E., Bernardini S., et al. Anti-Inflammatory and Proliferative Properties of Luteolin-7-O-Glucoside. Int. J. Mol. Sci. 2021;22:1321. doi: 10.3390/ijms22031321.", "ArticleIdList": ["10.3390/ijms22031321", "PMC7865871", "33525692"]}, {"Citation": "Zorov D.B., Juhaszova M., Sollott S.J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 2014;94:909\u2013950. doi: 10.1152/physrev.00026.2013.", "ArticleIdList": ["10.1152/physrev.00026.2013", "PMC4101632", "24987008"]}, {"Citation": "Turrens J.F. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552:335\u2013344. doi: 10.1113/jphysiol.2003.049478.", "ArticleIdList": ["10.1113/jphysiol.2003.049478", "PMC2343396", "14561818"]}, {"Citation": "Korshunov S.S., Skulachev V.P., Starkov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997;416:15\u201318. doi: 10.1016/S0014-5793(97)01159-9.", "ArticleIdList": ["10.1016/S0014-5793(97)01159-9", "9369223"]}, {"Citation": "Connolly N.M.C., Theurey P., Adam-Vizi V., Bazan N.G., Bernardi P., Bola\u00f1os J.P., Culmsee C., Dawson V.L., Deshmukh M., Duchen M.R., et al. Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases. Cell Death Differ. 2018;25:542\u2013572. doi: 10.1038/s41418-017-0020-4.", "ArticleIdList": ["10.1038/s41418-017-0020-4", "PMC5864235", "29229998"]}, {"Citation": "Norat P., Soldozy S., Sokolowski J.D., Gorick C.M., Kumar J.S., Chae Y., Ya\u011fmurlu K., Prada F., Walker M., Levitt M.R., et al. Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation. NPJ Regen. Med. 2020;5:22. doi: 10.1038/s41536-020-00107-x.", "ArticleIdList": ["10.1038/s41536-020-00107-x", "PMC7683736", "33298971"]}, {"Citation": "Nho J.-H., Jung H.-K., Lee M.-J., Jang J.-H., Sim M.-O., Jeong D.-E., Cho H.-W., Kim J.-C. Beneficial Effects of Cynaroside on Cisplatin-Induced Kidney Injury In Vitro and In Vivo. Toxicol. Res. 2018;34:133\u2013141. doi: 10.5487/TR.2018.34.2.133.", "ArticleIdList": ["10.5487/TR.2018.34.2.133", "PMC5903139", "29686775"]}, {"Citation": "Yao H., Shang Z., Wang P., Li S., Zhang Q., Tian H., Ren D., Han X. Protection of Luteolin-7-O-Glucoside Against Doxorubicin-Induced Injury Through PTEN/Akt and ERK Pathway in H9c2 Cells. Cardiovasc. Toxicol. 2016;16:101\u2013110. doi: 10.1007/s12012-015-9317-z.", "ArticleIdList": ["10.1007/s12012-015-9317-z", "25724325"]}, {"Citation": "Chen S., Yang B., Xu Y., Rong Y., Qiu Y. Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells. Mol. Med. Rep. 2018;17:7156\u20137162. doi: 10.3892/mmr.2018.8774.", "ArticleIdList": ["10.3892/mmr.2018.8774", "PMC5928668", "29568918"]}, {"Citation": "Wang Y., Guo S.-H., Shang X.-J., Yu L.-S., Zhu J.-W., Zhao A., Zhou Y.-F., An G.-H., Zhang Q., Ma B. Triptolide induces Sertoli cell apoptosis in mice via ROS/JNK-dependent activation of the mitochondrial pathway and inhibition of Nrf2-mediated antioxidant response. Acta Pharmacol. Sin. 2018;39:311\u2013327. doi: 10.1038/aps.2017.95.", "ArticleIdList": ["10.1038/aps.2017.95", "PMC5800476", "28905938"]}, {"Citation": "Chauhan D., Li G., Hideshima T., Podar K., Mitsiades C., Mitsiades N., Munshi N., Kharbanda S., Anderson K.C. JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J. Biol. Chem. 2003;278:17593\u201317596. doi: 10.1074/jbc.C300076200.", "ArticleIdList": ["10.1074/jbc.C300076200", "12665525"]}, {"Citation": "Che X.-F., Moriya S., Zheng C.-L., Abe A., Tomoda A., Miyazawa K. 2-Aminophenoxazine-3-one-induced apoptosis via generation of reactive oxygen species followed by c-jun N-terminal kinase activation in the human glioblastoma cell line LN229. Int. J. Oncol. 2013;43:1456\u20131466. doi: 10.3892/ijo.2013.2088.", "ArticleIdList": ["10.3892/ijo.2013.2088", "24008433"]}, {"Citation": "Fan P., Yu X.-Y., Xie X.-H., Chen C.-H., Zhang P., Yang C., Peng X., Wang Y.-T. Mitophagy is a protective response against oxidative damage in bone marrow mesenchymal stem cells. Life Sci. 2019;229:36\u201345. doi: 10.1016/j.lfs.2019.05.027.", "ArticleIdList": ["10.1016/j.lfs.2019.05.027", "31085242"]}, {"Citation": "Schroeter H., Boyd C.S., Ahmed R., Spencer J.P.E., Duncan R.F., Rice-Evans C., Cadenas E. c-Jun N-terminal kinase (JNK)-mediated modulation of brain mitochondria function: New target proteins for JNK signalling in mitochondrion-dependent apoptosis. Biochem. J. 2003;372:359\u2013369. doi: 10.1042/bj20030201.", "ArticleIdList": ["10.1042/bj20030201", "PMC1223409", "12614194"]}, {"Citation": "Hanawa N., Shinohara M., Saberi B., Gaarde W.A., Han D., Kaplowitz N. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J. Biol. Chem. 2008;283:13565\u201313577. doi: 10.1074/jbc.M708916200.", "ArticleIdList": ["10.1074/jbc.M708916200", "PMC2376214", "18337250"]}, {"Citation": "Roos W.P., Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol. Med. 2006;12:440\u2013450. doi: 10.1016/j.molmed.2006.07.007.", "ArticleIdList": ["10.1016/j.molmed.2006.07.007", "16899408"]}, {"Citation": "Yue J., L\u00f3pez J.M. Understanding MAPK signaling pathways in apoptosis. Int. J. Mol. Sci. 2020;21:2346. doi: 10.3390/ijms21072346.", "ArticleIdList": ["10.3390/ijms21072346", "PMC7177758", "32231094"]}, {"Citation": "Hepp Rehfeldt S.C., Majolo F., Goettert M.I., Laufer S. c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer\u2019s Diseases. Int. J. Mol. Sci. 2020;21:9677. doi: 10.3390/ijms21249677.", "ArticleIdList": ["10.3390/ijms21249677", "PMC7765872", "33352989"]}, {"Citation": "Kandimalla R., Reddy P.H. Therapeutics of neurotransmitters in alzheimer\u2019s disease. J. Alzheimers Dis. 2017;57:1049\u20131069. doi: 10.3233/JAD-161118.", "ArticleIdList": ["10.3233/JAD-161118", "PMC5793221", "28211810"]}, {"Citation": "Ali T.B., Schleret T.R., Reilly B.M., Chen W.Y., Abagyan R. Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada. PLoS ONE. 2015;10:e0144337. doi: 10.1371/journal.pone.0144337.", "ArticleIdList": ["10.1371/journal.pone.0144337", "PMC4671709", "26642212"]}, {"Citation": "Abdul Manap A.S., Wei Tan A.C., Leong W.H., Yin Chia A.Y., Vijayabalan S., Arya A., Wong E.H., Rizwan F., Bindal U., Koshy S., et al. Synergistic Effects of Curcumin and Piperine as Potent Acetylcholine and Amyloidogenic Inhibitors With Significant Neuroprotective Activity in SH-SY5Y Cells via Computational Molecular Modeling and in vitro Assay. Front. Aging Neurosci. 2019;11:206. doi: 10.3389/fnagi.2019.00206.", "ArticleIdList": ["10.3389/fnagi.2019.00206", "PMC6718453", "31507403"]}, {"Citation": "Kalola U.K., Nguyen H. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2021. Galantamine."}, {"Citation": "Khan H., Amin S., Kamal M.A., Patel S. Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects. Biomed. Pharmacother. 2018;101:860\u2013870. doi: 10.1016/j.biopha.2018.03.007.", "ArticleIdList": ["10.1016/j.biopha.2018.03.007", "29635895"]}, {"Citation": "Orhan I., Kartal M., Tosun F., Sener B. Screening of various phenolic acids and flavonoid derivatives for their anticholinesterase potential. Z. Naturforsch. C J. Biosci. 2007;62:829\u2013832. doi: 10.1515/znc-2007-11-1210.", "ArticleIdList": ["10.1515/znc-2007-11-1210", "18274286"]}, {"Citation": "Istifli E.S., Sar\u0131k\u00fcrkc\u00fc C. Assessment of apigenin-7-glucoside and luteolin-7-glucoside as multi-targeted agents against Alzheimer\u2019s disease: A molecular docking study. Int. J. Plant Based Pharm. 2021;1:56\u201364."}, {"Citation": "Sevindik H.G., G\u00fcvenalp Z., Yerdelen K.\u00d6., Yuca H., Demirezer L.\u00d6. The discovery of potential anticholinesterase compounds from Achillea millefolium L. Ind. Crops Prod. 2015;76:873\u2013879. doi: 10.1016/j.indcrop.2015.05.088.", "ArticleIdList": ["10.1016/j.indcrop.2015.05.088"]}, {"Citation": "Liu M.-Y., Zeng F., Shen Y., Wang Y.-Y., Zhang N., Geng F. Bioguided Isolation and Structure Identification of Acetylcholinesterase Enzyme Inhibitors from Drynariae rhizome. J. Anal. Methods Chem. 2020;2020:2971841. doi: 10.1155/2020/2971841.", "ArticleIdList": ["10.1155/2020/2971841", "PMC7059089", "32185082"]}, {"Citation": "Jang S., Kelley K.W., Johnson R.W. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc. Natl. Acad. Sci. USA. 2008;105:7534\u20137539. doi: 10.1073/pnas.0802865105.", "ArticleIdList": ["10.1073/pnas.0802865105", "PMC2396685", "18490655"]}, {"Citation": "Zhang J.-X., Xing J.-G., Wang L.-L., Jiang H.-L., Guo S.-L., Liu R. Luteolin Inhibits Fibrillary \u03b2-Amyloid1-40-Induced Inflammation in a Human Blood-Brain Barrier Model by Suppressing the p38 MAPK-Mediated NF-\u03baB Signaling Pathways. Molecules. 2017;22:334. doi: 10.3390/molecules22030334.", "ArticleIdList": ["10.3390/molecules22030334", "PMC6155314", "28245546"]}, {"Citation": "Lee S.A., Park B.-R., Moon S.-M., Hong J.H., Kim D.K., Kim C.S. Chondroprotective Effect of Cynaroside in IL-1\u03b2-Induced Primary Rat Chondrocytes and Organ Explants via NF-\u03baB and MAPK Signaling Inhibition. Oxid. Med. Cell. Longev. 2020;2020:9358080. doi: 10.1155/2020/9358080.", "ArticleIdList": ["10.1155/2020/9358080", "PMC7003268", "32047580"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "14"}, {"Year": "2022", "Month": "2", "Day": "28"}, {"Year": "2022", "Month": "3", "Day": "3"}, {"Year": "2022", "Month": "3", "Day": "25", "Hour": "1", "Minute": "6"}, {"Year": "2022", "Month": "3", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["35328335", "PMC8949357", "10.3390/ijms23062914", "ijms23062914"]}}], "PubmedBookArticle": []}